GSK and Flagship to jointly fund up to $150 million upfront
July 2024- GSK and Flagship Pioneering (Flagship) announced they have entered a…
New Hope for Myelofibrosis Patients in Japan: GSK’s Omjjara Gains Approval
June 2024- GSK announced that Japan’s Ministry of Health, Labour and Welfare…
Six-month dosing could simplify treatment to support millions of patients with severe asthma
London, UK- 23 May 2024- GSK announced positive headline results from the…
GSK to become a founding partner of Fleming Initiative to fight AMR
May, 2024- Global biopharmaceutical company, GSK, will become the first founding partner…
GSK completes acquisition of Aiolos Bio
February 2024- GSK today announced that it has completed the acquisition of…
